ABVC News and Press, ABVC BioPharma Inc. From 11/13/23

ABVC BioPharma Inc. (ABVC) is expected to report for Q3 2023

2023-10-30 10:00:42 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...

2023-10-27 09:56:48 ET DENVER, Colo., Oct. 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BIO-key International Inc (NASDAQ: BKYI), Nerdwallet Inc (NASDAQ: NRDS), Apollomics Inc (NASDAQ: APLM), SeaSt...

2023-10-26 13:36:09 ET More on ABVC BioPharma ABVC looks to establish a healthcare center, buys 20% stake in real estate property ABVC stock rallies on Chinese licensing deal for psych drugs Financial information for ABVC BioPharma For further details see: ...

2023-10-26 09:56:15 ET DENVER, Colo., Oct. 26, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ABVC BioPharma Inc (NASDAQ: ABVC), PaxMedica Inc (NASDAQ: PXMD), TransCode Therapeutics Inc (NASDAQ: RNAZ), M...

2023-10-26 09:02:11 ET DENVER, Colo., Oct 26, 2023 ( www.247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC) stated this morning, that it entered into a binding term sheet regarding a multi-year, global licensing agreement with AiBtl BioPharma for the Company’s CNS drugs wit...

FREMONT, CA - ( NewMediaWire ) - October 26, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that it...

FREMONT, CA - ( NewMediaWire ) - October 17, 2023 -   ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced an update on the Company's eight-week ...

The Company Holds a US Patent for the Same Treatment FREMONT, CA - ( NewMediaWire ) - October 09, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hemato...

FREMONT, CA - ( NewMediaWire ) - August 23, 2023 -   ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that 60 subjects had been enrolled and 53 had co...